121 related articles for article (PubMed ID: 34390723)
1. Doxorubicin induces wide-spread transcriptional changes in the myocardium of hearts distinguishing between mice with preserved and impaired cardiac function.
Stamm P; Kirmes I; Palmer A; Molitor M; Kvandova M; Kalinovic S; Mihalikova D; Reid G; Wenzel P; Münzel T; Daiber A; Jansen T
Life Sci; 2021 Nov; 284():119879. PubMed ID: 34390723
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
[TBL] [Abstract][Full Text] [Related]
4. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
Grant MK; Seelig DM; Sharkey LC; Zordoky BN
Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
[TBL] [Abstract][Full Text] [Related]
5. GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.
Wang Y; Lei T; Yuan J; Wu Y; Shen X; Gao J; Feng W; Lu Z
Redox Biol; 2018 Jul; 17():25-34. PubMed ID: 29660505
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
[TBL] [Abstract][Full Text] [Related]
7. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
8. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
Zhang W; Deng J; Sunkara M; Morris AJ; Wang C; St Clair D; Vore M
J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995
[TBL] [Abstract][Full Text] [Related]
9. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
[TBL] [Abstract][Full Text] [Related]
10. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress.
Yang N; Ma H; Jiang Z; Niu L; Zhang X; Liu Y; Wang Y; Cheng S; Deng Y; Qi H; Wang Z
Biochem Biophys Res Commun; 2019 Sep; 517(1):111-117. PubMed ID: 31303273
[TBL] [Abstract][Full Text] [Related]
11. Nanoceria ameliorates doxorubicin induced cardiotoxicity: Possible mitigation via reduction of oxidative stress and inflammation.
Sangomla S; Saifi MA; Khurana A; Godugu C
J Trace Elem Med Biol; 2018 May; 47():53-62. PubMed ID: 29544808
[TBL] [Abstract][Full Text] [Related]
12. Irigenin treatment alleviates doxorubicin (DOX)-induced cardiotoxicity by suppressing apoptosis, inflammation and oxidative stress via the increase of miR-425.
Guo L; Zheng X; Wang E; Jia X; Wang G; Wen J
Biomed Pharmacother; 2020 May; 125():109784. PubMed ID: 32092815
[TBL] [Abstract][Full Text] [Related]
13. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
[TBL] [Abstract][Full Text] [Related]
14. S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice.
Pei XM; Tam BT; Sin TK; Wang FF; Yung BY; Chan LW; Wong CS; Ying M; Lai CW; Siu PM
Front Physiol; 2016; 7():334. PubMed ID: 27547188
[TBL] [Abstract][Full Text] [Related]
15. LongShengZhi capsule inhibits doxorubicin-induced heart failure by anti-oxidative stress.
Xu S; Wang Y; Yu M; Wang D; Liang Y; Chen Y; Liao C; Xie Z; Zhao B; Han J; Duan Y; Yang X
Biomed Pharmacother; 2020 Mar; 123():109803. PubMed ID: 31877550
[TBL] [Abstract][Full Text] [Related]
16. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
[TBL] [Abstract][Full Text] [Related]
17. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
[TBL] [Abstract][Full Text] [Related]
18. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
[TBL] [Abstract][Full Text] [Related]
19. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
20. NH
Huang X; Liu Y; Yang X; Lai S; Zhang Y; Gu J; Li H; Xie Y; Xia Y
Life Sci; 2019 Jun; 227():94-100. PubMed ID: 31004659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
